Diabetic Kidney Disease Update

Affiliations

¹ Department of Medicine, University of California San Diego, La Jolla, California, USA.
² Department of Medicine, Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Editorial

Christian Mende et al. J Diabetes. 2025 Sep.

. 2025 Sep;17(9):e70150.

doi: 10.1111/1753-0407.70150.

¹ Department of Medicine, University of California San Diego, La Jolla, California, USA.
² Department of Medicine, Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

No abstract available

Conflict of interest statement

The authors declare no conflicts of interest.

1. de Boer I. H., Khunti K., Sadusky T., et al., “Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO),” Kidney International 102, no. 5 (2022): 974–989. - PubMed
1. Xu C., Ha X., Yang S., Tian X., and Jiang H., “Advances in Understanding and Treating Diabetic Kidney Disease: Focus on Tubulointerstitial Inflammation Mechanisms,” Frontiers in Endocrinology 14 (2023): 1232790. - PMC - PubMed
1. Oda Y., Nishi H., and Nangaku M., “Role of Inflammation in Progression of Chronic Kidney Disease in Type 2 Diabetes Mellitus: Clinical Implications,” Seminars in Nephrology 43, no. 3 (2023): 151431. - PubMed
1. Mohandes S., Doke T., Hu H., Mukhi D., Dhillon P., and Susztak K., “Molecular Pathways That Drive Diabetic Kidney Disease,” Journal of Clinical Investigation 133, no. 4 (2023): e165654, 10.1172/JCI165654. - DOI - PMC - PubMed
1. Młynarska E., Buławska D., Czarnik W., et al., “Novel Insights Into Diabetic Kidney Disease,” International Journal of Molecular Sciences 25, no. 18 (2024): 10222. - PMC - PubMed